Analysts/Institutional Investor Meet/Con. Call Updates

July 23, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400051 Mumbai- 400001 (SYMBOL: THYROCARE) (SCRIP CODE: 539871) Sub: Audio Recording of post results earnings conference call held on July 23, 2026 Ref: Disclosure under Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, In continuation of our letter dated July 16, 2026 and in compliance with Regulation 30(6) read with Part A of Schedule III of the Listing Regulations, we wish to inform that the audio recording of earnings conference call with analysts and investors held today i.e., Thursday, July 23, 2026, at 06:00 P. M. (IST) with respect to our Company’s unaudited financial results for the quarter ended June 30, 2026, is available on the company’s website at https://investor.thyrocare.com/financials/quarterly-financial-results/. The transcript of the earnings call will be shared shortly. We request you to please take the same on record. Yours Faithfully, For Thyrocare Technologies Limited, Brijesh Kumar Company Secretary and Compliance Officer